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Caffeine therapy for apnoea of prematurity: Wake up to the fact that sex 
matters. 
Fiona B. McDonald1, Eugene M. Dempsey2,3, Ken D. O’Halloran1 
Departments of 1Physiology and 2Paediatrics and Child Health, School of Medicine, College 
of Medicine & Health, and 3Irish Centre for Fetal and Neonatal Translational Research 
(Infant), University College Cork, Cork, Ireland. 
The developmental continuum of multiple physiological systems in preparation for uterine to 
neonatal transition is abruptly interrupted by preterm birth. The immature choreography of 
sensory reflexes, central respiratory rhythm and pattern generation, and respiratory 
mechanics is such that preterm infants struggle to establish and maintain smooth airflow in 
and out of the lungs, a critical function required to achieve sufficient blood oxygenation and 
excretion of carbon dioxide. Advances in prenatal and postnatal care, including administration 
of antenatal corticosteroids, and enhancements in delivery room respiratory support, 
postnatal monitoring and nutritional management have collectively contributed to improved 
survival rates for preterm infants, especially the extreme preterm infant. The focus of 
neonatal care has now progressed towards reducing infant morbidity, thus maximising the 
quality of life of the vulnerable neonate both in the immediate and longer term. 
Apnoea of prematurity (AOP) remains a significant problem in the neonatal intensive care 
unit. AOP is characterised by intermittent cessations of respiratory airflow due to periodic 
central inspiratory neural quiescence, arising from brainstem network underdevelopment. 
Moreover, preterm infants have immature respiratory muscle composition and compliant 
lungs with little functional reserve capacity. Apnoeas are clinically significant events often 
accompanied by intermittent hypoxic and bradycardic episodes, requiring varying levels of 
intervention. Greater immaturity translates into greater incidence of apnoeas. Clinical studies 
of early life adversity and animal models employing exposures to chronic intermittent 
hypoxia, a cardinal feature of recurrent apnoea, have reported long-term deleterious effects 
on cardiorespiratory function and adverse long-term neurocognitive outcome. Male sex is 
associated with a higher incidence of preterm birth, higher mortality rate at the extremes of 
preterm gestation, and higher morbidity as determined by increased rates of brain injury, 
bronchopulomonary dysplasia, necrotising enterocolitis and poorer neurocognitive scores at 
follow up at 24 months. However, the influence of sex on AOP has not been adequately 
studied in the clinical setting.  
In this issue of Experimental Physiology, Bairam et al. 2018 retrospectively examined the 
records of over 24,000 infants delivered between 24-34 weeks’ gestational age, admitted to 
30 tertiary neonatal centres participating in the Canadian Neonatal Network between January 
2011 and December 2015. The main aim of the study was to investigate putative sex 
differences in the incidence of AOP and compare interventional treatment duration between 
male and female infants. Bairam et al. 2018 report that AOP was more likely in infants born 
to mothers with significant clinical intervention including delivered by caesarean section, 
and/or receiving antenatal steroids and MgSO4 administration. The infants with AOP were 
born earlier, weighed less, had lower Apgar scores at five minutes and had significantly more 
morbidity than infants without AOP. These results suggest that infants with AOP are more 
immature and are exposed to a more stressful neonatal transitional period. Of interest, this 
is the first clinical study to reveal a small but significant increase in the incidence of AOP in 
females at 26-27 weeks’ gestational age compared with age-matched males, although this 
may relate to diagnosis in the context of multi-morbidity. Male sex is a risk factor for preterm 
respiratory distress syndrome, bronchopulmonary dysplasia, chronic lung disease, and lower 
respiratory tract infections. Physiologically, compared with females, males have: less fetal 
breathing movements in utero; delayed lung development, surfactant production and sodium 
transport efficiency prior to 32 weeks’ gestational age; larger lungs with lower peak flow 
rates; longer latencies to achieve SpO2 >90% after birth; and deficient antioxidant status. 
Despite the use of antenatal steroids to promote lung development, intrinsic sex differences 
confer increased vulnerability in males, whom traditionally require more supplemental 
oxygen, ventilatory support and surfactant use than preterm females.  
Caffeine administration is the main therapeutic strategy for the treatment of AOP. Almost 
90% of the cohort with AOP were treated with caffeine. Caffeine cessation was used as a 
proxy for the resolution of AOP. Interestingly, despite the higher incidence of AOP in extreme 
preterm females, Bairam et al. 2018 report prolonged administration of caffeine in males born 
less than 28 weeks’ gestational age. Although this study did not standardise criteria for the 
diagnosis of AOP, or caffeine initiation or discontinuation, it nevertheless suggests important 
sex differences both in extreme preterm and also late preterm infants, which have a relatively 
low incidence of chronic lung disease. The authors reasonably posit that the data are 
supportive of more rapid respiratory maturation in females compared with males.  
Clinically, respiratory support with prolonged caffeine administration may be warranted in 
males to limit further stress exposure. Remarkably, 64% of preterm infants ≤33 weeks’ 
gestational age at birth had pathological apnoeas seven days after caffeine discontinuation 
(Doyle et al., 2016); importantly, extended caffeine administration minimised intermittent 
hypoxia exposure in a similar cohort (Rhein et al., 2014). In future studies, examination of the 
relationship between sex, caffeine concentrations and durations of use, and intermittent 
oxygen desaturations are warranted to support evidence-based standardisation of caffeine 
initiation, dosage and withdrawal in the treatment of AOP. Perhaps caffeine does not serve 
extreme preterm male infants as well as their female counterparts and adjuvant therapies 
such as antioxidants (Lavoie and Tremblay, 2018) and/or sex hormones (Joseph et al., 2018) 
should be explored.  
The causal factors precipitating intrinsic male vulnerability are not understood; however, 
there is evidence of sexual disparity in genetics, sex steroid hormone concentrations and 
receptor expression, and metabolism. Animal studies also provide evidence of respiratory 
vulnerability in males such as exaggerated hypoxia-induced blood oxygen desaturation, post-
hypoxia respiratory depression and higher free-radical production in rat pups, and 
hypercapnic acidosis and prolonged oxygen supplementation requirement in preterm lambs. 
These studies illustrate greater respiratory depression and increased oxidative stress in males 
compared with females during early life. Based on the evidence from their translational 
animal models, Bairam et al. 2018 suggest that enhanced GABAergic inhibition of the central 
respiratory network is a plausible factor underpinning male vulnerability. In addition, sex 
steroid hormones likely play a pivotal role; males lack oestrogenic protection, while 
androgens can affect respiratory control and plasticity. Bairam et al. 2018 propose that 
perinatal stress increases testosterone in males, which compromises respiratory 
development.  
Despite male sex being repeatedly highlighted as a significant risk factor for poorer outcomes 
following preterm birth, there is a paucity of clinical information on the mechanisms 
underlying this risk and little sex-specific management in the neonatal intensive care unit. It 
is time that sex is routinely incorporated into clinical and basic neonatal research study 
designs, which may in time inform stratified approaches to the treatment of AOP. An 
improved understanding of sex-specific requirements of preterm infants may lead to 
optimised strategies to better support ventilation, avoid the long-term harmful sequelae of 
early life oxidative stress and inflammation, and ensure that male and female infants not only 
survive, but thrive. 
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